Literature DB >> 9474236

Psychometric analysis of the University of Wisconsin Interstitial Cystitis Scale: implications for use in randomized clinical trials.

J E Goin1, D Olaleye, K M Peters, B Steinert, K Habicht, G Wynant.   

Abstract

PURPOSE: A psychometric analysis of the University of Wisconsin Interstitial Cystitis Scale was conducted on 30 females previously enrolled in a phase II double-blind randomized controlled trial evaluating the efficacy of six weekly intravesical instillations of TICE BCG. The analyses were to: (1) evaluate the adequacy of the seven individual IC component items for measuring the range of patient responses; (2) verify the 2-factor (IC versus reference) construct of the scale; (3) evaluate the internal consistency and reliability of the IC items; (4) better define the scale's applicability and limitations; and (5) if possible, make recommendations for improvements in the scale.
MATERIALS AND METHODS: Standard psychometric analyses were used to perform the evaluation, and included descriptive analysis of individual items, computing of item-total correlations and Cronbach's internal consistency measures, and the application of factor and Rasch analyses.
RESULTS: The original 7-item IC scale was found to have ceiling effects that could limit its use in detecting small therapeutic differences. It was also found that the Pelvic item originally assigned to the reference set of items of the scale should be included as an IC item when used in a comparable IC population. After including this item into the IC scale Cronbach's alpha was 0.84, compared with 0.82.
CONCLUSIONS: The UW-IC Scale has psychometric properties similar to other measurement instruments used in clinical research, and appears worthy of further study in well-characterized IC populations. The reference items suggest that IC patients do not indiscriminately report high values for generalized body complaints, but do so on bladder related symptoms as recorded by the IC items of the scale. Although the scale has limitations it appears applicable for use in future IC intervention clinical trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474236

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Changes in urine markers and symptoms after bladder distention for interstitial cystitis.

Authors:  Deborah R Erickson; Allen R Kunselman; Christina M Bentley; Kenneth M Peters; Eric S Rovner; Laurence M Demers; Marcia A Wheeler; Susan K Keay
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

2.  Diagnosis of interstitial cystitis June 2007.

Authors:  Lesley K Carr; Jacques Corcos; J Curtis Nickel; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

3.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

4.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

5.  Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.

Authors:  Harris E Foster; Philip M Hanno; J Curtis Nickel; Christopher K Payne; Robert D Mayer; David A Burks; Claire C Yang; Toby C Chai; Karl J Kreder; Kenneth M Peters; Emily S Lukacz; Mary P FitzGerald; Liyi Cen; J Richard Landis; Kathleen J Propert; Wei Yang; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2010-03-29       Impact factor: 7.450

6.  First evidence of neosaxitoxin as a long-acting pain blocker in bladder pain syndrome.

Authors:  Valentin Manríquez; Daniela Castro Caperan; Rodrigo Guzmán; Michel Naser; Veronica Iglesia; Nestor Lagos
Journal:  Int Urogynecol J       Date:  2015-01-09       Impact factor: 2.894

7.  Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.

Authors:  Mari Imamura; Neil W Scott; Sheila A Wallace; Joseph A Ogah; Abigail A Ford; Yann A Dubos; Miriam Brazzelli
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

8.  Bayesian multivariate growth curve latent class models for mixed outcomes.

Authors:  Benjamin E Leiby; Thomas R Ten Have; Kevin G Lynch; Mary D Sammel
Journal:  Stat Med       Date:  2012-09-07       Impact factor: 2.373

9.  Assessing UK specialists' knowledge of the diagnostic criteria for painful bladder syndrome/interstitial cystitis.

Authors:  Fiona Marsh; Mary A E Garthwaite; Jennifer Southgate; Carmel Ramage
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-12-21

10.  Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo.

Authors:  Kathleen Joy Propert; Robert Mayer; J Curtis Nickel; Christopher K Payne; Kenneth M Peters; Valerie Teal; David Burks; John W Kusek; Leroy M Nyberg; Harris E Foster
Journal:  J Urol       Date:  2007-12-21       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.